Newborn Screening Act of 2004

Comprehensive Dangerous Drugs Act of 2002

Law regulating drug testing in the Philippines, aka R.A. No. 9165

9165

Republic Act No. ___ is aka Comprehensive Dangerous Drugs Act of 2002

Department of Health (DOH)

Responsibilities: Licensing, accrediting, establishing drug test networks, and more.

July 11, 2003

when was Implementing Rules and Regulations for Drug Testing Laboratories Accreditation promulgated?

Department of Health (DOH)

who was Implementing Rules and Regulations for Drug Testing Laboratories Accreditation promulgated?

October 2003

when was Interim Drug Test Operations and Management Information System (IDTOMIS)?

April 2006

when was Integrated Drug Test Operations and Management Information System (IDTOMIS) promulgated

IDTOMIS

Integrated system for data management and monitoring drug testing operations.

January 5, 2009

nationwide rollout by DOH of IDTOMIS

R.A. No. 6425

Republic Act also known as Dangerous Drugs Act of 1972

R.A. No. 6425

Republic Act No. 9165 repealed what RA?

102

number of sections of Republic Act No. 9165

DTL Classifications

Categories based on ownership, institutional character, and service capability

Chain of Custody

Procedure ensuring proper handling and documentation of specimens

Active Metabolites

Metabolites tested to determine drug presence in the body

Proficiency Testing

Evaluation to ensure accurate and reliable drug testing results

Investigation of Violations

Process to address breaches of drug testing regulations

Prohibited Drugs Threat

Concern for human dignity due to drug abuse's societal impact

R.A. 10586

Anti-Drunk and Drugged Driving Act revoking driver's license drug test requirement

Mandatory Drug Testing

Compulsory testing for specific groups like military, students, and public officials

Random Drug Testing

Unscheduled testing for various individuals like candidates for public office

Licensed Physician Supervision

Authorized to oversee at least 10 Drug Testing Laboratories

Drug Analyst Qualifications

Professionals like chemists, pharmacists, or medical technologists qualified for drug analysis

Specimen Collector

Personnel responsible for collecting specimens for drug testing

Laboratory Head Responsibility

Overall accountability for the drug testing facility's activities

Screening Laboratory Staff

Requires a licensed chemist, medical technologist, pharmacist, or chemical engineer

Confirmatory Laboratory Head

Position held by a pathologist or a physician with clinical laboratory management training

Institution-based DTLs

Located within institutions like hospitals and operate as part of the establishment

Freestanding DTLs

Independent facilities located outside institutional premises

Screening Laboratories

Capable of conducting initial screening tests for drug presence

Confirmatory Laboratories

Equipped for qualitative and quantitative drug examinations

Government DTLs

Operated by national, provincial, or municipal government entities

Private DTLs

Privately owned and funded drug testing facilities

Institution-based DTL Head

Position held by a licensed physician, chemist, medical technologist, pharmacist, or chemical engineer

Licensed Physician Supervision Limit

Allowed to supervise a minimum of 10 Drug Testing Laboratories

Licensed Chemist

Full-time chemist with training in chromatography and spectroscopy

Proficiency Test

Test administered by NRL for confirmatory laboratory staff

Accreditation

Formal authorization by DOH for compliant drug testing entities

Immunoassay

Required equipment for screening laboratory in drug testing

Tamper-Evident Seal

Seal used to secure specimen container in drug testing

Gas Chromatography-Mass Spectrometer

Equipment required for confirmatory drug testing

High-Performance Liquid Chromatography-Mass Spectrometer

Equipment for confirmatory drug testing ensuring accuracy

Specimen Collection

Process of gathering urine, blood, or other samples for drug testing

Confirmatory Test

Quantitative test to identify specific drugs or metabolites

Screening Test

Qualitative test to identify presumptively positive specimens

Enzyme Immunoassay

Analytical method used in drug testing for screening

Thin-Layer Chromatography

Chromatographic method for separating substances in drug testing

Hyphenated Technique

Combination of advanced technologies for confirmatory drug testing

Chromatogram

Graphical representation of separated compounds in drug testing

Negative Screening Result

Outcome indicating absence of drugs in initial drug test

Positive Confirmatory Result

Outcome indicating presence, identity, and concentration of drugs

Revocation of Accreditation

Potential consequence for failing to confirm positive screening results

Test Result Form

Document provided to client/donor with drug test outcome

Drug Testing Kit

Kit membrane required for DOH test submissions

Validity Period

Test results remain valid for one year

Shabu

Synthetic methamphetamine hydrochloride

Marijuana

Cannabis plant with psychoactive properties

Certificate of Accreditation

Issued after meeting DOH requirements

National Reference Laboratory

Conducts proficiency tests for DTLs

False Test Result

May lead to license suspension or revocation

Violations

Acts leading to suspension or revocation of license

HFSRB

Authority monitoring accredited DTLs

COA Renewal

Application filed 90 days before expiry

PT Failure

Affects DTL accreditation status

PT Results

Determines lab performance and accreditation

COA Conditions

Specific requirements for accreditation

Accreditation Transfer

Not allowed without notification to the Bureau

Accreditation Visibility

Must be displayed publicly in the lab

Accreditation Duration

Valid for one or two years based on lab type

Accreditation Assignment

Cannot be transferred to another party

Accreditation Changes

Notification required for management changes

Accreditation Location

Separate accreditation for different lab premises

Accreditation Requirements

Minimum standards set by the DOH

Accreditation Monitoring

On-site visits by HFSRB or CHD

Accreditation Revocation

Possible for non-compliance with standards

Accreditation Conditions

Specific limitations established during survey

Accreditation Survey

Basis for granting accreditation

Newborn Screening Act of 2004

Legislation enacted on July 7, 2004, ensuring a national system for newborn screening.

National Newborn Screening System

Policy to offer newborn screening to prevent mental retardation and death.

Republic Act No. 9288

Also known as the Newborn Screening Act of 2004, approved on July 7, 2004.

Implementing Rules and Regulations

Guidelines issued to execute the Newborn Screening Act effectively.

Expanded Newborn Screening (ENBS)

Enhanced screening panel detecting 28+ newborn disorders.

Maple Syrup Urine Disease (MSUD)

Disorder included in the NBS Panel of Disorders in 2012.

Congenital Disorders

Conditions present at birth, detectable through newborn screening.

Heritable Conditions

Traits inherited from parents leading to mental retardation or death if untreated.

Newborn

Child from complete delivery to 30 days old.

Newborn Screening (NBS)

Process detecting heritable conditions in newborns through blood testing.

Expanded Newborn Screening Panel

Increased NBS coverage from 6 to 28 types of congenital disorders.

Endocrine Disorders

Defects involving endocrine hormones, like congenital hypothyroidism and adrenal hyperplasia.

Congenital Hypothyroidism

Disorder affecting thyroid hormone production leading to mental retardation.

Congenital Adrenal Hyperplasia (CAH)

Group of disorders from enzymatic defects in steroid biosynthesis.

MSUD Metabolite

Leucine, tested in Maple Syrup Urine Disease.